Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health”
In a panel discussion, executives from Noom, Omada, Virta and Twin Health discussed how they…
Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health”
In a panel discussion, executives from Noom, Omada, Virta and Twin Health discussed how they are going beyond the pill in their GLP-1 strategy and responded to a question about whether they will exist two-to-three years from now. The post Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health” appeared…
Argenx Adds Oral Peptides to Its Immunology Strategy With $550M UNP Acquisition
Argenx’s Unnatural Products acquisition brings a macrocyclic peptides discovery platform for developing oral peptide drugs. The deal brings a new modality to Argenx, whose immunology R&D had focused on antibodies. The post Argenx Adds Oral Peptides to Its Immunology Strategy With $550M UNP Acquisition appeared first on MedCity News.
At the Helm of eHealth Exchange, Doug Dietzman Eyes New Use Cases for Data Sharing
Organization’s new president says one area of focus will by CMS’ new requirements for payers
Simulation-Guided Clinical Trials: Is EU Law Ready?
Simulations do not replace human judgment: they inform it, making transparent what would otherwise remain a “black box.” EU law does not require them today; but a proportionate embrace, in the right legislative vehicle, with clear methodological standards, and without crushing noncommercial research, could make trials safer, faster, cheaper, and more reliable, without sacrificing rigor….
AI and the Future of Revenue Cycle Management
Upcoming Healthcare Innovation webinar explores how health systems can use AI to improve financial performance, streamline operations, and reduce administrative burden.
Nkarta Autoimmune Disease Cell Therapy’s First Human Data Show Safety, Signs of Efficacy
Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic sclerosis, during the American College of Rheumatology annual in Orlando this week. The biotech is part of a growing group of companies developing therapies that reset the immune system to treat autoimmune disease. The post Nkarta Autoimmune…
Stop Testing AI Against Doctors. Test Doctors With AI.
By MANUEL PINILLA Every few months a new study reports that an AI model has outperformed doctors on a set of diagnostic cases. The latest one I’ve read came out in Science in October: Microsoft’s MAI-DxO, tested on 304 complex cases from the New England Journal of Medicine and run as step-by-step simulations, reached the…
What’s Driving the Consumerization of Healthcare?
Patients increasingly expect convenient, consumer-focused healthcare experiences, panelists said at the recent MedCity INVEST Digital Health Conference. The post What’s Driving the Consumerization of Healthcare? appeared first on MedCity News.
Missing the Point: Isolation Alone Will Not Build AI Safety
Treating AI agents like contract nurses and minimizing their access to critical patient information certainly reduces potential risk. But, it also minimizes key opportunities. The post Missing the Point: Isolation Alone Will Not Build AI Safety appeared first on MedCity News.
Our Reporters Discuss Healthcare Costs — And What Changes the Midterms May Portend
KFF Health News chief Washington correspondent Julie Rovner discussed how Congress can combat the rising cost of healthcare on WAMU’s 1A on Nov. 5, healthcare affordability on MS NOW’s Money, Power, Politics With Stephanie Ruhle on Oct. 30, and the politics of healthcare on Slate’s What Next podcast on Oct. 27. Click here to hear…
